Dr. Emilia Fabian, PhD is performing consultations in internal medicine, cardiology and anti-aging medicine, diagnostical tests. Personalized therapies.
Emilia Fabian, MD, PhD - curriculum vitae
Education
1981-1987: |
M.D., Uzshorod State University, Medical Faculty Uzshorod, former Soviet Union (diploma with honour) |
1996: |
Specialist in Internal Medicine |
1998: |
Specialist in Cardiology |
2002: |
Specialist in Clinical Pharmacology |
2005: |
PhD |
Spoken languages
Russian (high level)
English (medium level C)
Ukranian fluently
Clinical practice
1987-1994: |
Internal Department, Beregovo District Hospital |
1994-2001: |
Department of Cardiology, Central Hospital of Ministry of Internal Affairs, Budapest |
2001-2005: |
Elizabeth Hospital, Cardiology, Out-Patient Department |
2001: |
Istenhegyi Private Clinic, Internal Medicine and Cardiology, Head of the Out- Patient Department |
2005-2010: |
Istenhegyi Private Clinic, director and co-owner |
2011- |
Fabian Medical & Anti-Aging Clinic, Internal Medicine and Cardiology, Anti-Aging Medicine, Founder |
Postgraduate trainings
1991: |
Postgraduate courses in Internal Medicine (2 months), Lvov State University, Lvov, Ukraine |
1994: |
Postgraduate training in Cardiology (1 months), Debrecen University Medical School, Debrecen, Hungary |
1995: |
Postgraduate training in Internal Medicine (6 months), Haynal Imre University of Health Sciences, Budapest, Hungary |
1999: |
Training in echocardiography and stress echocardiography (1 month), Institute of Clinical Physiology, Pisa, Italy |
1999: |
"Heart Failure - current concepts and future options", European Heart House, Nice, France |
2004: |
2nd Department of Internal Medicine and Cardiology Centre, Faculty of Medicine, Szeged, Hungary |
2005: |
PhD dissertation "Ultrasound assessment of endothelial-dependent flow-mediated dilatation of the brachial artery: ready for the clinical arena?" |
2009: |
European Society of Sexual Medicine |
2010: |
American Academy of Anti-Aging Medicine |
2010: |
World Congress of Anti-Aging Medicine |
2011: |
International Conference on Longevity and Healthy Medicine |
2011: |
Anti-Ageing Conference London |
2012: |
3rd European Congress on Preventive, Regenerative and Anti-Aging Medicine |
2013: |
Anti-Ageing Conference London |
2014: |
Bio-Identical Hormones, Hormon Replacement Therapy in your Practice by Dr.Thierry Hertoghe |
Grants
2000: granted the tittle of "European Cardiologist" by the European Board for the Specialty of Cardiology
Fields of professional interest
Exercise ECG, perfusion scintigraphy, echocardiography, stress echocardiography, vascular ultrasound, endothelial function, flow mediated dilatation, clinical pharmacology, cardiovascular and hormonal anti-aging, erectile dysfunction caused by cardiovascular disease and their therapy,cardiovacsular therapy optimalization.
Memberships
Member of the Hungarian Society of Cardiology 1996
Member of the European Society of Cardiology 1998
Member of the Echocardiography Working Group of the ESC 2000
Member of the Hungarian Society of Hypertension 1998
Member of the Hungarian Society of Obesity 2000
Member of the Hungarian Society of Sexual Medicine 2008
Member of the European Society of Sexual Medicine 2009
WOSAAM 2010
American Academy of Anti-Aging Medicine 2010
Hungarian Society of Anti-Aging Medicine 2010
List of publications
I.) Fekete F., Fábián E. A hatékonyság és a mellékhatások vizsgálata erekciós zavarok sildenafil kezelése során. Orvosi Hetilap, 2000;1:4-712.
II.) Fábián E. A Viagra (sidenafil) alkalmazhatóságának és biztonságosságának hazai vizsgálata szívbetegek és cardiovasculáris rizikófaktorokkal rendelkező betegek körében. Cardioscan.2000;1D:12-14.
III.) Fábián E., Varga A. A simvastatin kezelés hatása hypercholesterinaemiás, coronaria X szindrómás betegek endothelfunkciójára. Orvosi Hetilap 2002; 36:2063-67.
IV.) Nagy L, Bajko S, Fábián E., Farkas K, Fazekas Á, Forster T, Járai Z, Kolozsvári E, Kovács I, Pálinkás A, Pécsváradi Zs, Rónaszéki A, Varga A, Vereckey G. Magyar konszenzus az artéria brachialis áramlásfüggő flow mediated vasodilatációjána vizsgálatához. Érbetegségek 2003;2:47-50.
V.) Farkas K, Fabian E, Kolossvary E, Jarai Z, Farsang Cs. Noninvasive assessment of endothelial dysfunction in essential hypertension; comparison of the flow mediated dilatation of the brachial artery with forearm microvascular reactivity. Int J Angiology 2003;12:224-28.
VI.) Fabian E, Varga A, Picano E, Vajo Z, Ronaszeki A, Csanady M. Effect of Simvastatin on Endothelial Function in Cardiac Syndrome -X Patients. Am J Cardiol 2004;94:652-55, (IF: 3,059)
VII.) Nagy L, Fábián E., Kovács I. Carvedilol és metoprolol vérnyomáscsökkentő és endothel funkcióra kifejtett hatásának összehasonlítása hypertoniás, 2-es típusú diabetes mellitusban szenvedő betegeken. Cardiologia Hungarica 2004;34:178-83.
VIII.) Fábián E., Csanády M. Simvastatin hatása coronaria-X szindrómás betegek terhelésre jelentkező ST-depressziójára és endothel funkciójára. Cardiologia Hungarica 2004
IX.) Farkas K, Fabian E, Kovacs L. Quinapril Improves Endothelial Function in Postmenopausal Hypertensive. Kidney Blood Press Res 2008;31:226-233. (IF 1,268)
Abstracts
I.) Fabian E, Pacetti E, Nemes B, Varga A, Morelos M, Rossi PC, Stock I, Picano E. Exercise perfusion scintigraphy positivity is associated with peripheral endothelial dysfunction in patients with normal coronary arteries. Proceedings of the International Stress Echo Meeting, Florence, Italy, 1999;45.
II.) Pacetti E, Talarico L, Varga A, Morelos M, Fabian E, Nemes B, Stock I, Rossi PC. Angina pectoris e disfunzione vascolare periferica in pazienti con scintigrafia miocardica da sforzo positiva ed albero coronarico angiograficamente normale. 4 Congresso Nazionale FADOI. 5-8 Maggio 1999,Genova. Book of proceedings, 27.
III.) Fábián E., Pacetti E, Nemes B, Varga A, Morelos M, Rossi PC, Stock I. Picano E. Perifériás endothel dysfunctio pozitív perfúziós szívizomscintigraphiával és negatív coronarographiával rendelkező betegekben. Cardiologia Hungarica. Supplementum 1999;2:71.
IV.) Varga A, Pratali L, Fabian E, Pacetti E, Nemes B, Morelos M, Stock I, Rossi PC, Picano E. Exercise perfusion scintigraphy positivity is associated with peripheral vascular endothelial dysfunction in patients with normal coronary arteries. Eur Heart J 1999;20 (S):1100 A. (IF:6,131)
V.) R. Amyot, A.Varga, M. Morelos, E. Fabian, O. Rodriguez, L .Pratali, E. Picano. Stress induced ST segment depression: anatomic lie or physiologic truth. Proceedings of the International Stress Echo Meeting, Pisa, Italy, 2000;45.
VI.) Fabian E, Varga A, Pacetti E, Pratali L, Morelos M, Rossi PC, Stock I, Picano E. Exercise perfusion scintigraphy positivity is associated with peripheral vascular endothelial dysfunction in patients with normal coronary arteries. J Am Coll Cardiol, 2000; 35:482 A (IF:6,278)
VII.) Fabian E, Varga A, Plonska E, Tomcsányi J, Bedros RJ. Effect of statin therapy on the coronary and endothelial function in cardiac syndrome-X patients. Proceedings of the 8th Alpe-Adria Cardiology Meeting, Portoroz, Slovenia, 2000;51.
VIII.) Varga A, Morelos M, Fabian E, Rodriguez O, Pratali L, Picano E. The effect of systemic endothelial dysfunction and coronary artery disease on electrocardiographic and functional signs of ischemia during stress. J Am Coll Cardiol 2000;35 :422 A (IF:6,278)
IX.) Fábián E., Varga A, Morelos M, Pratali L, Stock I, Picano E. A szisztémás endothelium diszfunkció és a koszorúsérbetegség kapcsolata a stressz indukálta iszkémia funkcionális és EKG paramétereivel. Cardiologia Hungarica. Supplementum 2000;2:17.
X.) Fabian E, Varga A, Tomcsányi J, Stock I, Picano E. The Beneficial Effect of Statin Therapy on Endothelial Function and Exercise-Induced Ischemia in Hypercholesterolemic Patients with Cardiac Syndrome X. Circulation 2000? 102: 2403 A. (IF:10,255)
XI.) Fabian E, Varga A, Tomcsanyi J, Stock I, Picano E. The Beneficial Effect of Statin Therapy on Endothelial Function and Exercise-Induced Ischaemia in Hypercholesterolemic Patients with Cardiac Syndrome X. Proceedings of the 4 th annual meeting of the Working Group on Echocardiography of the ESC, Lisbon, Portugal, 2000;21:22.
XII.) Fábián E., Varga A. statin kezelés jótékony hatása a szisztémás endothelium funkcióra coronária X syndromás betegekben. Cardiologia Hungarica. Supplementum 2001?2:95.
XIII.) Fábián E., Farkas K, Kolossvary E, Járai Z, Farsang Cs. Esszenciális hypertóniás betegek endothel diszfunkciójának non-invazív vizsgálati módszerei: az a. brachiális flow-mediált dilatációjának és az alkar mikrovaszkuláris reaktivitásának összehasonlítása. Cardiologia Hungarica. Supplementum 2002; 2:79.
XIV.) Nagy L, Fábián E., Tálosi L. Hypertóniás betegek áramlás-függgő dilatációjának dinamikája. Cardiologia Hungarica. Supplementum 2002; 2:80.
XV.) Fabian E, Varga A, Picano E, Soos P, Csanady M. The Chronic Statin Therapy Exerts Beneficial Effect on Systemic Endothelial Function and Exercise-Induced Ischemia in Hypercholesterolemic Patients with Cardiac Syndrome X. J Am Coll Cardiol 2002;39:219B. (IF:6,278)
XVI.) Farkas K, Fabian E, Kolossvary E, Jarai Z, Farsang Cs. Noninvasive assessment of endothelial dysfunction in essential hypertension; comparison of the forearm microvascular reactivity with flow mediated dilatation of the brachial artery. Journal of Hypertens 2002; 20: 290 A. (IF:3,534)
XVII.) Nagy L, Fábián E., Kovács I, Rónaszéki A. Carvedilol és metoprolol vérnyomáscsökkentő és endothel funkcióra kifejtett hatásának összehasonlítása hypertoniás, 2-es típusú diabetes mellitusban szenvedő betegeken. Cardiologia Hungarica, Supplementum 2004;2:26.
XVIII.) Fabian E, Nagy L, Kovacs I, Csanady M. Comparison of the Effects of Carvedilol and Metoprolol on Blood Pressure and Endothelial Function in Patients with Hypertension and type-2 Diabetes Mellitus. Eur J of Echocardiography. 2004; 5 (S): 51.
Clinical Pharmacological Studies
1998-1999: |
Effect of simvastatin on endothelial function, phase IV, Principal investigator |
1999-2000: |
MOLGEOM/III/99.1., Multinational, phase III b, Principal investigator |
1999-2000: |
Effect of monopril on endothelial function, phase IV, Principal investigator |
2000-2001: |
BRX 235-CLT-P2-001, phase II, Co-investigator |
2002-2004: |
PEP, Multinational, phase IV, Head of the Echo-lab in Hungary |
2002-2003: |
Comparison of effects of carvedilol and metoprolol on endothelial function, phase IV, Principal investigator |
2003-2004: |
Effect of quinalapril on endothelial function, phase IV, Co-investigator |
2007-2008: |
CSPP100A2333, phase III, Principal investigator |
2007-2008: |
D3569C0007, phase III, Principal investigator |
2007-2008: |
CEPO906A2303, phase III, Co-investigator |
2009-2010: |
CL3-16257-068 study, phase III, Principal investigator |